The role of SNAREs in post-Golgi trafficking.
Lead Research Organisation:
University of Cambridge
Department Name: Clinical Biochemist
Abstract
The inside of a cell is organized into a series of compartments (organelles) with each organelle having a defined function. Once a protein has been made or modified in one organelle, its function or activity is often required somewhere else. The cell therefore has to transport the protein to the site where it is needed, this is accomplished by packaging the proteins into a small lipid bound packages (vesicles) that brake off from one organelle and fuse with another. The aim of my research is to understand how these vesicles know with which organelles they should fuse. This research will increase our fundamental understanding of how cells function and may give insight into how defects in these processes cause diseases.
Technical Summary
One of the most fundamental unresolved questions in cell biology is how cells manage to preserve the organization and integrity of the endocytic and exocytic systems, while maintaining the transport of lipids and proteins between these specialized organelles. Proteins and lipids are transported between these organelles via small membrane bound transport vesicles, which bud from one compartment and fuse with another, thereby delivering their contents. The targeting and fusion of these vesicles with membranes is regulated in part by the specific interactions of a family of molecules known as SNAREs. In mammalian cells there are at least 38 SNAREs, each one being localized to a different compartment and involved in a subset of transport pathways. The aim of my research is to functionally define the SNAREs involved in Trans Golgi Network (TGN) to endosome and TGN to cell surface transport, by inhibiting SNARE function in combination with quantitative transport assays. To achieve this, I have generated a library of antibodies and siRNAs specific to 14 post-Golgi SNAREs and will use them in combination with flow cytometry based assays for measuring post-TGN trafficking. I also plan to identify the function of the vesicle SNARE VAMP4, by characterizing a VAMP4 knock out mouse that I am currently having generated. The proposed research will provide insight into how specificity is achieved in membrane transport and may also provide a framework for better understanding diseases caused by defects in membrane trafficking to lysosome and lysosome related organelles.
Publications

Gordon DE
(2021)
Quantitative Flow Cytometry-Based Assays for Measuring Constitutive Secretion.
in Methods in molecular biology (Clifton, N.J.)

Jonker CTH
(2018)
Vps3 and Vps8 control integrin trafficking from early to recycling endosomes and regulate integrin-dependent functions.
in Nature communications

Gordon DE
(2017)
VAMP3/Syb and YKT6 are required for the fusion of constitutive secretory carriers with the plasma membrane.
in PLoS genetics

Chiaruttini G
(2016)
The SNARE VAMP7 Regulates Exocytic Trafficking of Interleukin-12 in Dendritic Cells.
in Cell reports

Gokhale A
(2015)
The N-ethylmaleimide-sensitive factor and dysbindin interact to modulate synaptic plasticity.
in The Journal of neuroscience : the official journal of the Society for Neuroscience


Zlatic SA
(2013)
Chemical-genetic disruption of clathrin function spares adaptor complex 3-dependent endosome vesicle biogenesis.
in Molecular biology of the cell

Sahlender D
(2013)
Uncoupling the Functions of CALM in VAMP Sorting and Clathrin-Coated Pit Formation
in PLoS ONE

Jacob A
(2013)
Rab40b regulates trafficking of MMP2 and MMP9 during invadopodia formation and invasion of breast cancer cells.
in Journal of cell science

Kent HM
(2012)
Structural basis of the intracellular sorting of the SNARE VAMP7 by the AP3 adaptor complex.
in Developmental cell
Description | BBSRC project grant |
Amount | £549,679 (GBP) |
Funding ID | BB/S009566/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 04/2019 |
End | 04/2022 |
Description | Research Grant |
Amount | £358,756 (GBP) |
Funding ID | BB/L022389/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2013 |
End | 02/2017 |
Description | Research Grant |
Amount | £358,756 (GBP) |
Funding ID | BB/L022389/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2014 |
End | 04/2018 |
Title | Pharmacologically regulated constitutive secretion cell line |
Description | We have developed a cell line that expresses a pharmacologically regulated reporter construct that can be used to measure constitutive secretion. In conjunction with this system we have a developed a high throughput flowcytometry based assay for measuring this process. |
Type Of Material | Technology assay or reagent |
Year Produced | 2008 |
Provided To Others? | Yes |
Impact | We have used this cell line to identify new genes involved in constitutive secretion. This cell lines has been used in over 10 publications and is being used in over 20 laboratories around the world. |
Title | SNARE siRNA and antibody library |
Description | We have generated an siRNA library to all of the SNAREs encoded in the human genome. In addition we have obtained and generated antibodies to the majority of these proteins. |
Type Of Material | Antibody |
Year Produced | 2008 |
Provided To Others? | Yes |
Impact | We have used this siRNA library to define the role of SNAREs in constitutive secretion (manuscript in preparation). Collaborators are using this library to define the role of SNAREs in endosome to TGN transport and autophagosome lysosome fusion. |
Title | V4 genetrap mouse |
Description | We have created a V4 genetrap mouse in collaboration with Lexicon Pharmaceuticals. Disruption of V4 causes hypercholesterolemia indicating that SNAREs play a novel role in cholesterol homeostasis. |
Type Of Material | Model of mechanisms or symptoms - mammalian in vivo |
Provided To Others? | No |
Impact | The V4 genetrap mouse will be a powerful tool for investigating the role of SNAREs in cholesterol biology and will be a useful model of hypercholesterolemia. Currently, we are preparing a manuscript focused on the characterisation of these mice. |
Description | Autophagy and secretion |
Organisation | University of Cambridge |
Department | Cambridge Institute for Medical Research (CIMR) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We have been investigating the role of the secretory pathway in autophagy. |
Collaborator Contribution | Providing tools and reagents. |
Impact | We have published a paper in 2010 (20855506). |
Start Year | 2008 |
Description | Charcot-Marie-Tooth disease |
Organisation | University of Cambridge |
Department | Cambridge Institute for Medical Research (CIMR) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We helped analyse the function of the protein SH3TC2. |
Collaborator Contribution | They performed the localisation experiments on SH3TC2. |
Impact | We have published a paper in 2010 (20028792). |
Start Year | 2009 |
Description | Secretion screen |
Organisation | Medical Research Council (MRC) |
Department | MRC Laboratory of Molecular Biology (LMB) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We analysed the function of several genes identified in a genome wide dsRNA screen. |
Impact | We have published a manuscript in 2010 (19942856). |
Start Year | 2008 |
Title | NOVEL METHOD |
Description | The invention relates to a method of cell selection by using a nucleic acid molecule comprising a first nucleic acid sequence encoding a streptavidin binding peptide and a second nucleic acid sequence encoding a cell surface protein. The invention also relates to nucleic acid molecules, vectors, cells and kits for use with said method. |
IP Reference | WO2015189604 |
Protection | Patent granted |
Year Protection Granted | 2015 |
Licensed | No |
Impact | Currently in discussions with companies to licence this technology. |
Description | Talks for school children |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Type Of Presentation | Poster Presentation |
Geographic Reach | International |
Primary Audience | Schools |
Results and Impact | I have given several talks for school children in 2010/2011. I have communicated my research to approximately 80 children. The children seemed interested in biomedical research. |
Year(s) Of Engagement Activity | 2010,2011 |